Entity
Kineta
Created in 2008
- BETA
Up & running (A)
Existing signals show a regular activity Social networks
920 3,671 3,671Activities
Entity types
Location
Seattle, WA, USA
Seattle
United States of America
Employees
Scale: 11-50
Estimated: 29
Engaged corporates
7
0 4Added in Motherbase
1 year, 8 months ago
biotech Description
Value proposition
KA (Nasdaq)
Developing next-generation immunotherapies for cancer patients!
Kineta is a clinical stage biotechnology company with a mission to develop next-generation immunotherapies that transform patients’ lives.
Antivirals, Chronic Pain, Immuno-oncology, Biodefense, Immunology, Virology, Lassa fever, and Neuroscience
Next-generation immunotherapies for cancer patients – Kineta Inc.
Kineta fills a void in the biopharmaceutical industry by efficiently advancing first-in-class novel immunotherapies from discovery to proof of concept.
https://kinetabio.com/
Corporate interactions BETA
| Corporate | Type | Tweets | Articles | |
|---|---|---|---|---|
 | Biotechnology Innovation Organization | Other 29 Sep 2023 | | |
 Financial Times Media, Newspaper Publishing | Financial Times Media, Newspaper Publishing | Other 27 Nov 2017 | | |
 Amgen Biotechnology, Biotechnology Research | Amgen Biotechnology, Biotechnology Research | Other 28 Aug 2018 | | |
 Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Bristol Myers Squibb Pharmaceutical, Pharmaceutical Manufacturing | Other 5 Jun 2019 | | |
 MSD Pharmaceutical, Pharmaceutical Manufacturing | MSD Pharmaceutical, Pharmaceutical Manufacturing | Other 11 Jan 2022 | | |
 Nasdaq Finance, Financial Services | Nasdaq Finance, Financial Services | Other 23 Dec 2020 27 Jul 2023 | | |
 Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Boehringer Ingelheim Pharmaceutical, Pharmaceutical Manufacturing, Animal Health | Other 26 Oct 2021 | | |
Similar entities
Loading...
Last news Show all articles
Loading...
Social network dynamics